Procter & Gamble Health Limited, formerly Merck Limited, is an Indian-based company specializing in the manufacturing and marketing of pharmaceuticals and chemicals. The company operates through two main divisions: Pharmaceuticals, which includes treatments for cardiovascular, metabolic, and various other diseases, and Chemicals, focusing on bulk drugs and active pharmaceutical ingredients. Established in 1967, it became a public limited company in 1981 and is a 51% subsidiary of German firm Merck KGaA. Over the years, Procter & Gamble Health has expanded its product offerings and production capacities, launching popular brands such as Neurobion Forte and Livogen Iron.
The company has undergone several transformations, including the sale of certain business segments and the introduction of new products like Lipigo and Whisper Choice Aloe Vera. It has faced regulatory challenges, notably a significant government ban affecting some of its drugs and pricing disputes. Despite these challenges, Procter & Gamble Health continues to focus on pharmaceuticals, leveraging its diverse product lineup to address various health needs.
